[go: up one dir, main page]

EA003255B1 - Комбинация производных тетрагидропиридинов и ингибиторов ацетилхолинэстеразы для лечения старческой деменции по типу альцгеймера - Google Patents

Комбинация производных тетрагидропиридинов и ингибиторов ацетилхолинэстеразы для лечения старческой деменции по типу альцгеймера Download PDF

Info

Publication number
EA003255B1
EA003255B1 EA200000412A EA200000412A EA003255B1 EA 003255 B1 EA003255 B1 EA 003255B1 EA 200000412 A EA200000412 A EA 200000412A EA 200000412 A EA200000412 A EA 200000412A EA 003255 B1 EA003255 B1 EA 003255B1
Authority
EA
Eurasian Patent Office
Prior art keywords
tetrahydropyridine
trifluoromethylphenyl
ethyl
biphenylyl
alkyl
Prior art date
Application number
EA200000412A
Other languages
English (en)
Russian (ru)
Other versions
EA200000412A1 (ru
Inventor
Жан-Пьер Маффран
Филипп Субрие
Жан-Поль Терранова
Original Assignee
Санофи-Синтелябо
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714322A external-priority patent/FR2771007B1/fr
Priority claimed from FR9714324A external-priority patent/FR2771006B1/fr
Application filed by Санофи-Синтелябо filed Critical Санофи-Синтелябо
Publication of EA200000412A1 publication Critical patent/EA200000412A1/ru
Publication of EA003255B1 publication Critical patent/EA003255B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EA200000412A 1997-11-14 1998-11-09 Комбинация производных тетрагидропиридинов и ингибиторов ацетилхолинэстеразы для лечения старческой деменции по типу альцгеймера EA003255B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714322A FR2771007B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR9714324A FR2771006B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
PCT/FR1998/002384 WO1999025363A1 (fr) 1997-11-14 1998-11-09 Association de principes actifs, notamment de tetrahydropyridines et d'agents inhibiteurs de l'acetylcholinesterase, pour le traitement de la demence senile du type alzheimer

Publications (2)

Publication Number Publication Date
EA200000412A1 EA200000412A1 (ru) 2000-12-25
EA003255B1 true EA003255B1 (ru) 2003-02-27

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000412A EA003255B1 (ru) 1997-11-14 1998-11-09 Комбинация производных тетрагидропиридинов и ингибиторов ацетилхолинэстеразы для лечения старческой деменции по типу альцгеймера

Country Status (27)

Country Link
EP (1) EP1030671A1 (et)
JP (1) JP2001523642A (et)
KR (1) KR100599350B1 (et)
CN (1) CN1243540C (et)
AU (1) AU743228B2 (et)
BG (1) BG64819B1 (et)
BR (1) BR9814035A (et)
CA (1) CA2309966A1 (et)
CO (1) CO4980891A1 (et)
DZ (1) DZ2649A1 (et)
EA (1) EA003255B1 (et)
EE (1) EE04235B1 (et)
HU (1) HUP0100098A3 (et)
ID (1) ID24933A (et)
IL (2) IL136122A0 (et)
IS (1) IS5482A (et)
MY (1) MY120461A (et)
NO (1) NO20002450L (et)
NZ (1) NZ504420A (et)
OA (1) OA11464A (et)
PL (1) PL194597B1 (et)
SA (1) SA98190747B1 (et)
SK (1) SK286040B6 (et)
TR (1) TR200001262T2 (et)
TW (1) TW585766B (et)
UY (1) UY25247A1 (et)
WO (1) WO1999025363A1 (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2389937T (pt) * 2002-06-14 2018-10-26 Toyama Chemical Co Ltd Composição farmacêutica para melhorar as funções cerebrais
US20060160079A1 (en) * 2002-08-07 2006-07-20 Lane Roger M Methods for the treatment of dementia based on apo e genotype
CN1520818A (zh) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物
NZ555693A (en) 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
WO2015116923A1 (en) 2014-01-31 2015-08-06 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
CN110869011B (zh) * 2017-05-15 2024-01-05 考格尼申治疗股份有限公司 用于治疗神经退行性疾病的组合物
KR102224917B1 (ko) 2018-03-20 2021-03-09 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
WO2019182319A1 (ko) * 2018-03-20 2019-09-26 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
CN109265391B (zh) * 2018-11-13 2021-11-19 枣庄学院 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
EP0813416B1 (en) * 1995-03-06 2005-05-25 Interneuron Pharmaceuticals Incorporated Reduction of infarct volume using citicoline
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
WO1999025363A1 (fr) 1999-05-27
CN1243540C (zh) 2006-03-01
KR100599350B1 (ko) 2006-07-12
JP2001523642A (ja) 2001-11-27
BG64819B1 (bg) 2006-05-31
PL194597B1 (pl) 2007-06-29
CO4980891A1 (es) 2000-11-27
SK7112000A3 (en) 2000-10-09
DZ2649A1 (fr) 2004-12-28
NO20002450D0 (no) 2000-05-11
NZ504420A (en) 2003-08-29
TW585766B (en) 2004-05-01
IL136122A0 (en) 2001-05-20
SK286040B6 (sk) 2008-01-07
AU743228B2 (en) 2002-01-24
EP1030671A1 (fr) 2000-08-30
EE04235B1 (et) 2004-02-16
TR200001262T2 (tr) 2001-01-22
PL340500A1 (en) 2001-02-12
SA98190747B1 (ar) 2006-11-04
EE200000290A (et) 2001-06-15
EA200000412A1 (ru) 2000-12-25
HUP0100098A3 (en) 2001-12-28
AU1160999A (en) 1999-06-07
HUP0100098A2 (hu) 2001-07-30
IS5482A (is) 2000-05-09
IL136122A (en) 2006-07-05
BG104428A (en) 2001-08-31
CN1285742A (zh) 2001-02-28
CA2309966A1 (en) 1999-05-27
OA11464A (en) 2003-11-18
KR20010032099A (ko) 2001-04-16
ID24933A (id) 2000-08-31
BR9814035A (pt) 2000-09-26
NO20002450L (no) 2000-07-14
UY25247A1 (es) 2001-05-31
MY120461A (en) 2005-10-31

Similar Documents

Publication Publication Date Title
AU743609B2 (en) Use of cholinesterase inhibitors to treat disorders of attention
US20030144255A1 (en) Compositions for prevention and treatment of dementia
NZ547152A (en) Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
AU2003271103B2 (en) Solid preparation
CA2690110A1 (en) Ampa receptor antagonists for neuropathic pain
MXPA02011610A (es) Combinacion de sustancia activa que contiene un opioide que tiene una estructura tipo fentanilo y cetamina.
EA003255B1 (ru) Комбинация производных тетрагидропиридинов и ингибиторов ацетилхолинэстеразы для лечения старческой деменции по типу альцгеймера
MXPA01010904A (es) Utilizacion del saredutant y de sus sales farmaceuticamente aceptables para la preparacion de medicamentos utiles en el tratamiento o la prevencion del conjunto de los trastornos del humor, de los trastornos de adaptacion o de los trastornos mixtos a
US20050148614A1 (en) Combination of active ingredients for the treatment of senile dementia of the Alzheimer type
AU2004229179A1 (en) Combinations of paroxetine and 4- (S) - (4-Acetyl-piperazin-1-yl) -2- (R)- (4-fluoro-2-methyl-phenyl -piperidine-1-carboxylic acid (1- (R) -(3,5-bis-trifluoromethyl-phenyl) -ethyl) methylamide for treatment of depression and / or anxiety
CA2188227C (en) Combination antiemetic therapy using nk-1 receptor antagonists
WO2014055047A1 (en) Combination of idebenone and donezepil
MXPA00004600A (en) Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
JPH0576925B2 (et)
US5326781A (en) Medicaments
FR2771006A1 (fr) Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR2771007A1 (fr) Association de principes actifs pour le traitement de la demence senile du type alzheimer
CA2768356A1 (en) Compositions comprising a cholinesterase inhibitor for treating cognitive disorders

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

TC4A Change in name of a patent proprietor in a eurasian patent

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU